Romatoid Artrit İlişkili Lenfadenopati

Okabe Y, Aoki T, Terasawa T, et al. Mediastinal and axillar lymphadenopathy in patients with rheumatoid arthritis: prevalence and clinical significance. Clinical Imaging. 2019;55:140-3. DOI: 10.1016/j.clinimag.2019.02.014

Satiş H, Erden A, Bilgin E, et al. Nationwide study: prevalence of rheumatoid factor and anti-citrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis. Turkish journal of medical sciences. 2024;54(5):949-55. DOI: 10.55730/1300-0144.5872

Takada H, Kanedo Y, Nakano K, et al. Clinicopathological characteristics of lymphoproliferative disorders in 232 patients with rheumatoid arthritis in Japan: A retrospective, multicenter, descriptive study. Modern Rheumatology. 2021;32(1):32-40.

King RL, Hsi ED. Reactive Lymphadenopathies. In: Jaffe ES, Arber DA, Campo E, et al. (Eds.) Hematopathology. Philadelphia: Elsevier; 2025. p. 159-184.

Medeiros LJ, Miranda RN. Rheumatoid Artritis-Related Lymphadenopathy. In: Medeiros LJ, Miranda RN (Eds.) Lymph Nodes and Extranodal Lymphomas. Philadelphia: Elsevier; 2018. p. 194-201.

Miranda RN, Khoury JD, Medeiros LJ. Atlas of Lymph Node Pathology (eBook). Springer Science+Business Media; 2013.

Lin T-S, Tsao T-Y, Chen S-W, et al. Protracted Tonsillitis as an Atypical Initial Manifestation of Methotrexate-Induced EBV-Positive Lymphoproliferative Disorder in Rheumatoid Arthritis: A Case Report and Literature Review. Diagnostics. 2025;15(12):1517. DOI: 10.3390/diagnostics15121517

Rodolfi S, Della-Torre E, Bongiovanni L, et al. Lymphadenopathy in the rheumatology practice: a pragmatic approach. Rheumatology. 2023;63(6):1484-93. DOI: 10.1093/rheumatology/kead644

Inamdar KV, Kini SR. Reactive and Malignant Lymphadenopathies. In: Kini SR (Ed.) Differential Diagnosis in Exfoliative and Aspiration Cytopathology. Philadelphia: Lippincott Williams & Wilkins, a Wolters Kluwer business; 2011. p. 543-569.

WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. Lyon (France): International Agency for Research on Cancer; 2024. (WHO classification of tumours series, 5th ed.; vol. 11). https://publications.iarc.who.int/637.

Gru, A. A., & O'Malley, D. P.. Autoimmune and medication-induced lymphadenopathies. Seminars in diagnostic pathology. 2018;35(1), 34–43. DOI: 10.1053/j.semdp.2017.11.015